Register
Login:
Share:
Email Facebook Twitter

PHARMA: Heat Biologics - a 'potentially transformative' lung cancer treatment, Phase II data Q3 2018 Watch here

Looking for big risk, big reward investing? See our exclusive Pharma video series from 'Biotech and Money'


Regulatory News


Notice of Q3 2017 Results

Thu, 2nd Nov 2017 17:08


RNS Number : 4516V
ATLAS Mara Limited
02 November 2017
 

2 November 2017

 

 

Notice to Publish Q3 2017 Results

 

Atlas Mara Limited ("Atlas Mara", or "the Company"), the sub-Saharan Africa financial services group, will publish its Q3 2017 results on Wednesday, 8 November 2017.  

 

 

Contact details

 

Investors:

Kojo Dufu, +1 212 883 4330

 

Media:

Teneo Blue Rubicon, +44 (20) 7260 2700

Anthony Silverman

 

 

About Atlas Mara

 

Atlas Mara Limited (LON: ATMA) is a financial services institution listed on the London Stock Exchange. Its vision is to create sub-Saharan Africa's premier financial services institution through organic and inorganic growth by combining the best of global institutional knowledge with extensive local insights. With a presence in seven sub-Saharan countries, Atlas Mara aims to be a positive disruptive force in the markets in which we operate by leveraging technology to provide innovative and differentiated product offerings, excellent customer service and accelerate financial inclusion in the countries in which the Company operates. For more information, visit www.atlasmara.com.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NORFSWFWEFWSESF





Back to Regulatory News


Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk




Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.